Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis | MicrobiomeTrials← Back to trialsNCT07711262
Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-08-18Est. Completion: 2027-10
Enrollment target: 550 participants Locations- The No.2 Hospital of Baoding, Baoding, Hebei, China
- Cangzhou Central Hospital, Cangzhou, Hebei, China
- Hebei General Hospital, Shijiazhuang, Hebei, China
- Hebei Provincial Hospital of Traditional Chinese Medicine, Shijiazhuang, Hebei, China
- The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei, China
- Baogang Hospital of Inner Mongolia, Baotou, Inner Mongolia, China
- Baotou Central Hospital, Baotou, Inner Mongolia, China
- Chifeng Municipal Hospital, Chifeng, Inner Mongolia, China
- The First People's Hospital of Yinchuan, Yinchuan, Ningxia, China
- Shandong Second Provincial General Hospital, Jinan, Shandong, China
- Linfen Central Hospital, Linfen, Shanxi, China
- First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China
- Second hospital of Shanxi Medical University, Taiyuan, Shanxi, China
- Shanxi Bethune Hospital, Taiyuan, Shanxi, China
- Beijing Tongren Hospital, Capital Medical University, Beijing, China
- Emergency General Hospital, Beijing, China
Other microbiome trials you might be interested in
PGM3 DeficiencyEosinophilic and/or Atopic DermatitisOSMR DeficiencyPrimary Localized Cutaneous AmyloidosisHereditary Alpha-tryptasemia
Background:
\- Allergic inflammation is central to allergy-related diseases and disorders, such as asthma, food allergi…
Bethesda, United States
Seasonal Allergic Rhinitis
The study is a multicenter, randomized, double-blind, placebo-controlled seamless and adaptive-designed phase IIb/III st…
Beijing, ChinaCompleted May 26, 2025
Peking University Third Hospital, Beijing, ChinaTianjin People's Hospital, Tianjin, China